Rheumatology Network Newsletter

To view this email as a web page, click here.

Failure to Lower Serum Urate in Gout Linked with Mortality

Failure to achieve a target serum urate level of below 6 mg/dL among patients with gout is an independent predictor of total and cardiovascular-related mortality, say researchers writing in RMD Open: Rheumatic & Musculoskeletal Diseases this month.

Rheumatoid Arthritis Pain Persists Despite TNF Inhibitor Use

Opioid use among patients with rheumatoid arthritis is prevalent, and while there is a small decrease in overall opioid use after tumor necrosis factor(TNF) inhibitor initiation, newly initiated opioid use after TNF inhibitor initiation may reflect an unmet need in pain management, say researchers writing in Rheumatology and Therapy this month.

Treatment Delays Associated with Prior Authorization

Prior authorization requirements are associated with treatment delays and prior authorization denials are associated with greater glucocorticoid exposure, say researchers writing in Arthritis Care & Research last month.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.